Cullinan Therapeutics (CGEM) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.42
-1.13
-0.83
-0.54

Details

Expected EPS
-0.97
Actual EPS
-0.82
Surprise EPS
0.15
Surprise Percent
+15.46%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.82 per share for Q2 2023.

0 Comments

Share your thoughts